-
Talabostat Mesylate: DPP4, FAP, and CARD8
2026-08-18
Talabostat mesylate (PT-100) is more than a DPP4/FAP inhibitor: it is a context-dependent probe of protease-regulated tumor and immune biology. This article connects extracellular target engagement with DPP9–CARD8 pyroptosis and translates that distinction into practical assay design.
-
DMXAA (Vadimezan): An Assay-First Mechanism Guide
2026-08-17
DMXAA (Vadimezan) is a vascular disrupting compound with DTD-inhibitory, VEGFR2-related, and pro-apoptotic activities. This assay-first guide explains how to distinguish tumor endothelial injury from endothelial STING-JAK1 biology and design more interpretable cancer biology research workflows.
-
Imipramine BA2970: Reliable Cell Assays
2026-08-17
A scenario-based guide to using Imipramine SKU BA2970 in viability, glioma autophagy, and HL-60 apoptosis workflows. It connects product handling recommendations with current lipidomics evidence while separating validated findings from exploratory assay design.
-
Stat3 Mediates Fyn-Driven Dopaminergic Neurodegeneration
2026-08-16
This zebrafish study identifies Stat3 as a downstream effector that cooperates with NF-κB in Fyn-driven dopaminergic neuron loss and microglial activation. Its cell-type-focused genetic model, live imaging, transcriptomics, and pathway inhibition provide a framework for studying neuroinflammatory mechanisms, while also defining limitations for translation to mammalian disease and gene editing studies.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-08-15
This guide explains how to use Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 for detecting HMGB1 in human, mouse, and rat research samples by Western blot, immunohistochemistry, and flow cytometry. It provides workflow-oriented setup and troubleshooting, but the reagent is for research use only and should not be treated as clinically validated or diagnostic.
-
PFOS Injury in HK-2 Cells: Ferroptosis and ER Stress
2026-08-15
The reference study links PFOS-induced injury in human proximal tubular HK-2 cells with ferroptosis-associated iron and lipid-peroxidation changes alongside activation of the endoplasmic reticulum stress pathway. Its marker-based design offers a practical framework for nephrotoxicity studies while also showing why causal rescue experiments are needed before assigning therapeutic relevance.
-
TMEM16F in Kupffer Cells Protects the Liver from Listeria
2026-08-14
The reference study identifies Kupffer cell TMEM16F, rather than TMEM16F in T or B cells, as a key determinant of liver protection during Listeria monocytogenes infection. Its cell-specific genetic models connect calcium-activated lipid scrambling and plasma-membrane repair with reduced Kupffer cell death, controlled inflammation, and preserved hepatic metabolism.
-
Exo1 B6876 for Reliable Exocytosis Assays
2026-08-14
This scenario-based guide explains how Exo1 (SKU B6876) can improve interpretation and control of cell-based exocytosis, membrane trafficking, viability, and cytotoxicity workflows. It covers mechanism, formulation, protocol design, data interpretation, vendor selection, and the limits of translating exocytic-pathway findings into tumor extracellular vesicle research.
-
Exosomal SNORD52 Activates JAK2/STAT6 in HCC
2026-08-13
This study identifies hepatoma cell-derived exosomal SNORD52 as an intercellular regulator that promotes M2 macrophage polarization through the JAK2/STAT6 axis. Its experimental framework links a specific non-coding RNA cargo with tumor-associated immune remodeling and provides a basis for testing pathway-level interventions in hepatocellular carcinoma models.
-
Dovitinib (TKI-258) Workflow for RTK Cancer Studies
2026-08-13
Build more informative RTK experiments with Dovitinib, from concentration-response screening to phospho-ERK, STAT, and apoptosis readouts. A chamber-specific stem-cell study adds a useful experimental-design lesson: define cell state and lineage before interpreting pathway sensitivity.
-
EDC.HCl: Practical Coupling Workflow
2026-08-12
EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide synthesis, bioconjugation, and related in vitro workflows. It should be handled as a laboratory reagent only; the product dossier reports no in vivo or clinical data, and long-term storage of prepared solutions is not recommended.
-
Z-IETD-FMK: Mapping Death-Pathway Causality
2026-08-12
Z-IETD-FMK enables targeted interrogation of caspase-8, T cell proliferation inhibition, and TRAIL-mediated apoptosis inhibition. This article connects inhibitor choice with temporal, pathway-specific assay design and interprets new evidence on mitochondrial apoptosis without conflating pathway activity with phenotype.
-
AI-10-49 CBFβ-SMMHC Inhibitor Workflows
2026-08-11
This scenario-driven guide explains how AI-10-49, a selective leukemia oncoprotein CBFβ-SMMHC inhibitor, can support mechanistic, viability, proliferation, and cytotoxicity studies in inv(16) acute myeloid leukemia research. It covers SKU A8694 handling, assay design, target-engagement controls, interpretation, and practical product-selection criteria.
-
N-MYC/eIF4G1 Axis in inv(16) AML
2026-08-10
Peramangalam et al. identify a previously unrecognized MYCN enhancer and establish N-MYC-dependent control of eIF4G1 as a survival mechanism in inv(16) acute myeloid leukemia. The study connects CBFβ-SMMHC activity to a transcriptional and translational program that can be tested through integrated genomic, molecular, and patient-derived leukemia models.
-
Candida auris Antifungal Pipeline: Review Findings
2026-08-09
This systematic review maps the preclinical antifungal pipeline for multidrug-resistant Candida auris, integrating susceptibility data with evidence from neutropenic candidemia models. Its main practical contribution is a structured comparison of investigational classes while showing why MIC results, survival, and tissue fungal burden must be interpreted together.
442 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page